Spectrum Management Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Spectrum Management Group’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$4K	–	436
2021 Q3	$4K	Buy	+200	New	+$2.34K	﹤0.01%	363

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Spectrum Management Group's TRIL Position: Q4 2021 in Review

Spectrum Management Group sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 200 shares — an estimated $4K sold.

Spectrum Management Group first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Spectrum Management Group reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Spectrum Management Group sold 200 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $4K.
Spectrum Management Group first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Spectrum Management Group's Trillium Therapeutics Inc. position peaked at $4K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Spectrum Management Group's 13F filing for Q4 2021, filed 3 Feb 2022.